Market Overview

Earnings Scheduled For March 19, 2014

Related FDX
Markets Reverse Early Morning Gains Following Canadian Shooting
DHL Edges Land Rover As Most Valuable Brand Newcomer
Making Money With Charles Payne: 10/16/14 (Fox Business)
Related ESLT
UPDATE: Elbit Posts Upbeat Q2 Profit
4 Defense Stocks To Watch Amid Israeli - Palestinian Unrest
Making Money With Charles Payne: 09/25/14 (Fox Business)

FedEx (NYSE: FDX) is projected to report its Q3 earnings at $1.46 per share on revenue of $11.43 billion.

Elbit Systems (NASDAQ: ESLT) is estimated to report its Q4 earnings at $1.41 per share on revenue of $839.97 million.

General Mills (NYSE: GIS) is projected to report its Q3 earnings at $0.64 per share on revenue of $4.41 billion.

Jabil Circuit (NYSE: JBL) is expected to post its Q2 earnings at $0.11 per share on revenue of $3.61 billion.

KB Home (NYSE: KBH) is estimated to report its Q1 earnings at $0.08 per share on revenue of $435.30 million.

Guess' (NYSE: GES) is expected to post its Q4 earnings at $0.79 per share on revenue of $762.94 million.

Vera Bradley (NASDAQ: VRA) is projected to report its Q4 earnings at $0.46 per share on revenue of $146.86 million.

Bacterin International Holdings (NYSE: BONE) is estimated to post a Q4 loss at $0.07 per share on revenue of $8.00 million.

CLARCOR (NYSE: CLC) is expected to post its Q1 earnings at $0.41 per share on revenue of $317.45 million.

Cintas (NASDAQ: CTAS) is projected to post its Q3 earnings at $0.69 per share on revenue of $1.13 billion.

Franco-Nevada (NYSE: FNV) is estimated to post its Q4 earnings at $0.22 per share on revenue of $96.32 million.

Tilly's (NYSE: TLYS) is expected to post its Q4 earnings at $0.18 per share on revenue of $139.75 million.

Herman Miller (NASDAQ: MLHR) is projected to post its Q3 earnings at $0.34 per share on revenue of $457.60 million.

Actuant (NYSE: ATU) is expected to report its Q2 earnings at $0.32 per share on revenue of $333.74 million.

The ExOne Company (NASDAQ: XONE) is estimated to post its Q4 earnings at $0.01 per share on revenue of $12.13 million.

Sinovac Biotech (NASDAQ: SVA) is projected to post a Q4 loss at $0.01 per share on revenue of $20.35 million.

Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

 

Related Articles (ATU + BONE)

Around the Web, We're Loving...

Get Benzinga's Newsletters